Sort
15,440 grants matching “organoids”
Gene-Environment interactions in Autism
$606,543Victor G. Corces · Emory University · R01 · FY2022 · ES
TGF beta and AKT signal-driven pathogenesis in keratoconus
$606,483Shukti Chakravarti · New York University School Of Medicine · R01 · FY2018 · EY
Modeling Normal and Abnormal Trophoblasts
$606,395Laura Clamon Schulz · University Of Missouri-Columbia · R01 · FY2024 · HD
IBIS-iPSC: Organoid modeling of cortical surface area hyperexpansion in autism spectrum disorder
$606,258Jason Louis Stein · Univ Of North Carolina Chapel Hill · R01 · FY2025 · MH
The role of Kit signaling in taste bud regeneration
$606,189Linda A Barlow · University Of Colorado Denver · R01 · FY2024 · DC
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
$606,154Cornelia M Ulrich · University Of Utah · R01 · FY2024 · CA
Deciphering epigenetically-regulated pathways to improve targeted therapy for invasion and metastasis in head and neck cancer
$606,038Sidharth Venkata Puram · Washington University · R01 · FY2025 · DE
Therapeutic Strategy to Treat Alzheimer's Disease by VGF Delivery into Brain
$606,012Jagdish Singh · North Dakota State University · R01 · FY2025 · AG
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen
$606,007Khashayarsha Khazaie · Mayo Clinic Arizona · R01 · FY2025 · CA
Genetically engineered human pluripotent stem cells as a platform to define the b
$605,970Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2014 · MH
Project 3: Enhanced Sensitivity of Tumors to Proton Beam Therapy: Mechanisms and Biomarkers.
$605,788David R Grosshans · Massachusetts General Hospital · P01 · FY2025 · CA
Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models
$605,693Lilia M Iakoucheva · University Of California, San Diego · R01 · FY2023 · ES
Immunoepigenetic targeting of MHC regulators in FAP
$605,411Roderick H Dashwood · Texas A&M University Health Science Ctr · R01 · FY2023 · CA
Basal cells in airway and alveolar remodeling
$604,959Barry R Stripp · Cedars-Sinai Medical Center · R01 · FY2025 · HL
Basal cells in airway and alveolar remodeling
$604,959Barry R Stripp · Cedars-Sinai Medical Center · R01 · FY2023 · HL
Basal cells in airway and alveolar remodeling
$604,959Barry R Stripp · Cedars-Sinai Medical Center · R01 · FY2022 · HL
Immune Exclusion in Cancer Immunotherapy
$604,941Riyue Bao · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DE
Immune Exclusion in Cancer Immunotherapy
$604,941Riyue Bao · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DE
Immune Exclusion in Cancer Immunotherapy
$604,941Riyue Bao · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DE
Pittsburgh Center for Kidney Research
$604,894Thomas R. Kleyman · University Of Pittsburgh At Pittsburgh · P30 · FY2018 · DK
Dissecting anti-ceramide scFv vascular mitigation of the Radiation GI Syndrome
$604,800Richard N Kolesnick · Sloan-Kettering Inst Can Research · U01 · FY2017 · AI
Exploiting ferroportin for cancer imaging and therapy
$604,800Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models
$604,748Lilia M Iakoucheva · University Of California, San Diego · R01 · FY2025 · ES
Predicting Endocrine Therapy Response In Male Breast Tumors
$604,746Philip M Spanheimer · Univ Of North Carolina Chapel Hill · R37 · FY2024 · CA
Environmental chemicals impair epigenetic suppression of the endogenous retrovirus HML-2 in human primordial germ cells, predisposing the next generation to malignancies through HML-2 reactivation
$604,191Toshihiro Shioda · Massachusetts General Hospital · R01 · FY2025 · ES